H. Fuder
Institut für klinische Pharmakologie Bobenheim
Grünstadt
Germany
Name/email consistency: high
- The alpha-glucosidase inhibitor voglibose (AO-128) does not change pharmacodynamics or pharmacokinetics of warfarin. Fuder, H., Kleist, P., Birkel, M., Ehrlich, A., Emeklibas, S., Maslak, W., Stridde, E., Wetzelsberger, N., Wieckhorst, G., Lücker, P.W. Eur. J. Clin. Pharmacol. (1997)